Loading…
Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies
Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists...
Saved in:
Published in: | Journal of biomedical materials research. Part B, Applied biomaterials Applied biomaterials, 2010-11, Vol.95B (2), p.475-480 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3 |
container_end_page | 480 |
container_issue | 2 |
container_start_page | 475 |
container_title | Journal of biomedical materials research. Part B, Applied biomaterials |
container_volume | 95B |
creator | Gautam, Shalini Korchagina, Elena Y. Bovin, Nicolai V. Federspiel, William J. |
description | Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010. |
doi_str_mv | 10.1002/jbm.b.31707 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883045928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1671274801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</originalsourceid><addsrcrecordid>eNp9kUtPGzEURq0KVCDtqns0Eguo0KR-jGN7mUaEh0IrFSqWlu25Q53OI7Un0Px7DCFZsGB17-J8R_fqQ-gLwUOCMf02t83QDhkRWHxA-4RzmhdKkp3tLtgeOohxnuAR5uwj2qNYCqmI2Ed3NwtwvvIuM23vbVeussrXPYTs5GY8_ZpZ35a-vc-cWRjn-1UG7R_TOmig7bO-ywI03QO8hPPxxuEhfkK7lakjfH6dA_R7enY7uchnP88vJ-NZ7lhRiJyJolLW2EooKMlIqopS60onpAErKZXMKUsNd4I7Iq3DypmSUEupAIZVxQboeO1dhO7fEmKvGx8d1LVpoVtGLSXDBVdJNEAn75JkJAgVhcQkoUdv0Hm3DG36QzPMRTqzkCxRp2vKhS7GAJVeBN-YsNIE6-dmdGpGW_3STKIPX51L20C5ZTdVJICsgUdfw-o9l776fr2R5uuMjz3832ZM-KtHggmu736ca1LMria3U65_sScoUqbX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3057689483</pqid></control><display><type>article</type><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</creator><creatorcontrib>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</creatorcontrib><description>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</description><identifier>ISSN: 1552-4973</identifier><identifier>ISSN: 1552-4981</identifier><identifier>EISSN: 1552-4981</identifier><identifier>DOI: 10.1002/jbm.b.31707</identifier><identifier>PMID: 20878917</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>ABO Blood-Group System - immunology ; ABO system ; Adsorption ; Antibodies ; Antibodies - blood ; Antibodies - isolation & purification ; antibody filter ; Antigens ; Antigens - chemistry ; Antigens - immunology ; Binding ; Biomedical materials ; Blood groups ; Blood volume ; Cyanogen ; Devices ; Dialysis ; fiber membranes ; Fibers ; Filtration - methods ; Graft rejection ; Hollow fiber membranes ; immunoaffinity absorption ; Immunoglobulin M ; Molecular Weight ; Monoclonal antibodies ; Oligosaccharides ; Polymers ; regenerative medicine ; Sodium hydroxide ; Surface activation ; Surface area ; Surface chemistry ; Surgical implants ; Ultrafiltration</subject><ispartof>Journal of biomedical materials research. Part B, Applied biomaterials, 2010-11, Vol.95B (2), p.475-480</ispartof><rights>Copyright © 2010 Wiley Periodicals, Inc.</rights><rights>2010 Wiley Periodicals, Inc.</rights><rights>Copyright Wiley Subscription Services, Inc. Nov 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</citedby><cites>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20878917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gautam, Shalini</creatorcontrib><creatorcontrib>Korchagina, Elena Y.</creatorcontrib><creatorcontrib>Bovin, Nicolai V.</creatorcontrib><creatorcontrib>Federspiel, William J.</creatorcontrib><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><title>Journal of biomedical materials research. Part B, Applied biomaterials</title><addtitle>J. Biomed. Mater. Res</addtitle><description>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</description><subject>ABO Blood-Group System - immunology</subject><subject>ABO system</subject><subject>Adsorption</subject><subject>Antibodies</subject><subject>Antibodies - blood</subject><subject>Antibodies - isolation & purification</subject><subject>antibody filter</subject><subject>Antigens</subject><subject>Antigens - chemistry</subject><subject>Antigens - immunology</subject><subject>Binding</subject><subject>Biomedical materials</subject><subject>Blood groups</subject><subject>Blood volume</subject><subject>Cyanogen</subject><subject>Devices</subject><subject>Dialysis</subject><subject>fiber membranes</subject><subject>Fibers</subject><subject>Filtration - methods</subject><subject>Graft rejection</subject><subject>Hollow fiber membranes</subject><subject>immunoaffinity absorption</subject><subject>Immunoglobulin M</subject><subject>Molecular Weight</subject><subject>Monoclonal antibodies</subject><subject>Oligosaccharides</subject><subject>Polymers</subject><subject>regenerative medicine</subject><subject>Sodium hydroxide</subject><subject>Surface activation</subject><subject>Surface area</subject><subject>Surface chemistry</subject><subject>Surgical implants</subject><subject>Ultrafiltration</subject><issn>1552-4973</issn><issn>1552-4981</issn><issn>1552-4981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kUtPGzEURq0KVCDtqns0Eguo0KR-jGN7mUaEh0IrFSqWlu25Q53OI7Un0Px7DCFZsGB17-J8R_fqQ-gLwUOCMf02t83QDhkRWHxA-4RzmhdKkp3tLtgeOohxnuAR5uwj2qNYCqmI2Ed3NwtwvvIuM23vbVeussrXPYTs5GY8_ZpZ35a-vc-cWRjn-1UG7R_TOmig7bO-ywI03QO8hPPxxuEhfkK7lakjfH6dA_R7enY7uchnP88vJ-NZ7lhRiJyJolLW2EooKMlIqopS60onpAErKZXMKUsNd4I7Iq3DypmSUEupAIZVxQboeO1dhO7fEmKvGx8d1LVpoVtGLSXDBVdJNEAn75JkJAgVhcQkoUdv0Hm3DG36QzPMRTqzkCxRp2vKhS7GAJVeBN-YsNIE6-dmdGpGW_3STKIPX51L20C5ZTdVJICsgUdfw-o9l776fr2R5uuMjz3832ZM-KtHggmu736ca1LMria3U65_sScoUqbX</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Gautam, Shalini</creator><creator>Korchagina, Elena Y.</creator><creator>Bovin, Nicolai V.</creator><creator>Federspiel, William J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope></search><sort><creationdate>201011</creationdate><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><author>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>ABO Blood-Group System - immunology</topic><topic>ABO system</topic><topic>Adsorption</topic><topic>Antibodies</topic><topic>Antibodies - blood</topic><topic>Antibodies - isolation & purification</topic><topic>antibody filter</topic><topic>Antigens</topic><topic>Antigens - chemistry</topic><topic>Antigens - immunology</topic><topic>Binding</topic><topic>Biomedical materials</topic><topic>Blood groups</topic><topic>Blood volume</topic><topic>Cyanogen</topic><topic>Devices</topic><topic>Dialysis</topic><topic>fiber membranes</topic><topic>Fibers</topic><topic>Filtration - methods</topic><topic>Graft rejection</topic><topic>Hollow fiber membranes</topic><topic>immunoaffinity absorption</topic><topic>Immunoglobulin M</topic><topic>Molecular Weight</topic><topic>Monoclonal antibodies</topic><topic>Oligosaccharides</topic><topic>Polymers</topic><topic>regenerative medicine</topic><topic>Sodium hydroxide</topic><topic>Surface activation</topic><topic>Surface area</topic><topic>Surface chemistry</topic><topic>Surgical implants</topic><topic>Ultrafiltration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gautam, Shalini</creatorcontrib><creatorcontrib>Korchagina, Elena Y.</creatorcontrib><creatorcontrib>Bovin, Nicolai V.</creatorcontrib><creatorcontrib>Federspiel, William J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of biomedical materials research. Part B, Applied biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gautam, Shalini</au><au>Korchagina, Elena Y.</au><au>Bovin, Nicolai V.</au><au>Federspiel, William J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</atitle><jtitle>Journal of biomedical materials research. Part B, Applied biomaterials</jtitle><addtitle>J. Biomed. Mater. Res</addtitle><date>2010-11</date><risdate>2010</risdate><volume>95B</volume><issue>2</issue><spage>475</spage><epage>480</epage><pages>475-480</pages><issn>1552-4973</issn><issn>1552-4981</issn><eissn>1552-4981</eissn><abstract>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20878917</pmid><doi>10.1002/jbm.b.31707</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-4973 |
ispartof | Journal of biomedical materials research. Part B, Applied biomaterials, 2010-11, Vol.95B (2), p.475-480 |
issn | 1552-4973 1552-4981 1552-4981 |
language | eng |
recordid | cdi_proquest_miscellaneous_883045928 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | ABO Blood-Group System - immunology ABO system Adsorption Antibodies Antibodies - blood Antibodies - isolation & purification antibody filter Antigens Antigens - chemistry Antigens - immunology Binding Biomedical materials Blood groups Blood volume Cyanogen Devices Dialysis fiber membranes Fibers Filtration - methods Graft rejection Hollow fiber membranes immunoaffinity absorption Immunoglobulin M Molecular Weight Monoclonal antibodies Oligosaccharides Polymers regenerative medicine Sodium hydroxide Surface activation Surface area Surface chemistry Surgical implants Ultrafiltration |
title | Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A41%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20antibody%20filter%20(SAF)%20binding%20capacity%20enhancement%20to%20remove%20anti-A%20antibodies&rft.jtitle=Journal%20of%20biomedical%20materials%20research.%20Part%20B,%20Applied%20biomaterials&rft.au=Gautam,%20Shalini&rft.date=2010-11&rft.volume=95B&rft.issue=2&rft.spage=475&rft.epage=480&rft.pages=475-480&rft.issn=1552-4973&rft.eissn=1552-4981&rft_id=info:doi/10.1002/jbm.b.31707&rft_dat=%3Cproquest_cross%3E1671274801%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3057689483&rft_id=info:pmid/20878917&rfr_iscdi=true |